Genetic Load and Phenotype in Aggressive AMD
NCT01650948 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2014-01-20
Summary
Patients with AMD will provide cheek cell samples to determine if their is a correlation between genotype (DNA markers) and phenotype (the type of AMD the patient has).
Conditions
- Age-related Macular Degeneration
Interventions
- DEVICE
-
RetnaGene AMD LDT
Sponsors & Collaborators
-
Sequenom, Inc.
lead INDUSTRY
Eligibility
- Min Age
- 50 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-07-31
- Primary Completion
- 2013-12-31
- Completion
- 2013-12-31
Countries
- United States
Study Locations
More Related Trials
-
Genetic Study of Age-Related Macular Degeneration
NCT00357578 ·Status: COMPLETED
-
Evaluation of R:GEN as Intervention in Subjects With Early Stages of AMD for Safety and Exploratory Efficacy Outcomes
NCT04776031 ·Status: COMPLETED ·Phase: NA
-
A Follow-up Study to Evaluate the Safety of RetinoStat® in Patients With Age-Related Macular Degeneration
NCT01678872 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
RGX-314 Gene Therapy Pharmacodynamic Study for Neovascular Age-related Macular Degeneration (nAMD)
NCT04832724 ·Status: COMPLETED ·Phase: PHASE2
-
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD
NCT04704921 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Safety And Tolerability Study Of RN6G In Patients With Dry, Age-Related Macular Degeneration
NCT00877032 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of RRG001 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)
NCT06141460 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Safety and Tolerability Study of AAV2-sFLT01 in Patients With Neovascular Age-Related Macular Degeneration (AMD)
NCT01024998 ·Status: COMPLETED ·Phase: PHASE1
-
Genetics in Non-response to Anti-VEGF Treatment in Exudative AMD
NCT01213667 ·Status: UNKNOWN ·Phase: PHASE4
-
VEGFA-targeting Gene Therapy to Treat Retinal and Choroidal Neovascularization Diseases
NCT05099094 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
LX102 in Patients With Neovascular Age-Related Macular Degeneration (nAMD)
NCT06198413 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Genetic Biomarkers for the Response to Anti-VEGF (Vascular Endothelial Growth Factor).Treatment in Wet Age-related Macular Degeneration (Wet ARMD)
NCT02762188 ·Status: COMPLETED ·Phase: NA
-
Evaluating RXI-109 to Reduce the Progression of Subretinal Fibrosis in Subjects With NVAMD
NCT02599064 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD
NCT05210803 ·Status: ENROLLING_BY_INVITATION
-
Randomized, Single-Masked, Long-Term, Safety and Tolerability Study of VEGF Trap-Eye in AMD
NCT00527423 ·Status: COMPLETED ·Phase: PHASE2
-
Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy
NCT03999801 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
A Study of EXG102-031 in Patients With wAMD (Everest)
NCT05903794 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I/II Study of SKG0106 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD)
NCT05986864 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD)
NCT01397409 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD
NCT00320775 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of AGN208397 in the Treatment of Macular Edema Associated With Retinal Vein Occlusion (RVO)
NCT01027650 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Tolerability Study of RO7171009 in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
NCT03295877 ·Status: COMPLETED ·Phase: PHASE1
-
Non-Interventional Long Term Follow-up Study of Participants Previously Enrolled in the RESTORE Study
NCT06162585 ·Status: ACTIVE_NOT_RECRUITING
-
Phase I Dose Escalation Safety Study of RetinoStat in Advanced Age-Related Macular Degeneration (AMD)
NCT01301443 ·Status: COMPLETED ·Phase: PHASE1
-
Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration
NCT01255462 ·Status: COMPLETED ·Phase: PHASE1